Personal profile
Research interests
My laboratory studies the pathogenic role of epigenetic regulators in prostate cancer development and progression, with a focus on the mechanisms by which these factors co-operate with transcription factors to drive tumor heterogeneity and resistance to various standard of care therapies such as radiotherapy, anti-androgen therapy and immune therapy. We combine basic science, pre-clinical and clinical studies with an emphasis on the translational impact with the goal of developing new diagnostics and therapeutics for novel cancer targets. We employ human prostate cell line, xenograft, and genetically engineered mouse models to address mechanisms of drug resistance and immune suppression in prostate cancers
Mentoring
My mentoring philosophy is based on recognizing individual talents, respecting their interests and inputs, and investing in individual development. I encourage diversity of thought, collaboration and team science that allow us to jointly bring our unique experiences to learn and grow. I work to create a lab environment which embodies scientific rigor, fellowship, growth mind-set and excitement for the work. I am very committed to fostering a culture of inclusive excellence across research. I have conducted research with students and fellows from diverse backgrounds believing in their potential. Regardless of their level, I train each of them to grow as scientists and as team members. Importantly, I spend one on one time with everyone to develop and advance their careers and provide guidance towards their interests.
Available to Mentor:
- Undergraduate Students
- Post-Baccalaureate Students
- PhD Students
- Postdocs
- Residents and Fellows
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Amino Terminal Acetylation of HOXB13 Regulates the DNA Damage Response in Prostate Cancer
Nguyen, D. T., Mahajan, U., Angappulige, D. H., Doshi, A., Mahajan, N. P. & Mahajan, K., May 2024, In: Cancers. 16, 9, 1622.Research output: Contribution to journal › Article › peer-review
Open Access -
Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression
Angappulige, D. H., Mahajan, N. P. & Mahajan, K., Apr 2024, In: Trends in Cancer. 10, 4, p. 369-381 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access18 Scopus citations -
Prostate-Specific Membrane Antigen–Targeted Imaging and Its Correlation with HOXB13 Expression
Angappulige, D. H., Barashi, N. S., Pickersgill, N., Weimholt, C., Luo, J., Shadmani, G., Tarcha, Z., Rayamajhi, S., Mahajan, N. P., Andriole, G. L., Siegel, B. A., Kim, E. H. & Mahajan, K., Aug 1 2024, In: Journal of Nuclear Medicine. 65, 8, p. 1210-1216 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis
Chouhan, S., Sridaran, D., Weimholt, C., Luo, J., Li, T., Hodgson, M. C., Santos, L. N., Le Sommer, S., Fang, B., Koomen, J. M., Seeliger, M., Qu, C. K., Yart, A., Kontaridis, M. I., Mahajan, K. & Mahajan, N. P., Dec 2024, In: Nature communications. 15, 1, 5629.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development
Barashi, N. S., Li, T., Angappulige, D. H., Zhang, B., O’Gorman, H., Nottingham, C. U., Shetty, A. S., Ippolito, J. E., Andriole, G. L., Mahajan, N. P., Kim, E. H. & Mahajan, K., Jan 2024, In: Cancers. 16, 1, 213.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations